Partager

Document IIF

Conception originale d'un cycle de lyophilisation pour une molécule sensible à la température.

An original freeze-drying cycle design for a temperature sensitive molecule.

Auteurs : LHOSPICE F.

Résumé

IPH1101/BrHPP is a new chemical entity and acts as an agonist of T Lymphocytes VG9D2. IPH1101 is currently tested in phase II clinical trials in some cancer indications. IPH1101 is a water soluble drug substance, highly hygroscopic. The drug substance is unstable in aqueous solution, and is sensitive to moisture content and temperature. Therefore IPH1101 has been formulated as a freeze-dried product (IPH1101 200 mg). The first freeze-drying cycle design had been developed for phase I clinical studies, with a "classical" temperature slope for each step. Unfortunately, this freeze-drying cycle didn't supply robust results; i.e. a part of IPH1101 drug product batch (up to 30%) must be removed due to a non conventional aspect. Therefore a most advanced knowledge on IPH1101 low temperature behaviour has been needed and a new approach to design freeze-drying cycle has been setup to supply clinical trials with pharmaceutically acceptable drug product.

Documents disponibles

Format PDF

Pages : 2007-3

Disponible

  • Prix public

    20 €

  • Prix membre*

    Gratuit

* meilleur tarif applicable selon le type d'adhésion (voir le détail des avantages des adhésions individuelles et collectives)

Détails

  • Titre original : An original freeze-drying cycle design for a temperature sensitive molecule.
  • Identifiant de la fiche : 2008-2756
  • Langues : Anglais
  • Source : New Ventures in Freeze-Drying
  • Date d'édition : 07/2007

Liens


Voir d'autres communications du même compte rendu (12)
Voir le compte rendu de la conférence

Indexation